State of the Art Infrastructure with DSIR recognized R&D Lab


 Aegis Lifesciences plant at Changodar, Ahmedabad, has state-of-the-art manufacturing facility fully equipped with best-in-class machinery to manufacture quality products at a very competitive price.

Aegis is in mode of continual improvement and expansion of manufacturing facility to take care of market need for next generation of medical devices.

With full-fledged state of art R&D infrastructure, Equipment and Manpower including collaboration activities with reputes Scientific and health care institutions in India and abroad, The R&D is well equipped to meet the requirements from Design, IPR, In-vitro testing, Design transfer meeting the highest standard of Regulatory requirements (ISO 13485: 2016 / Clause 7.2) / MRD, USFDA 510K and 21 CFR).

Aegis has been approved the DSIR accreditation (F.No. TU/ IV – RD/4698/2021) for its R&D Facility for the activities that had been undertaken in the past and for projects in future.


Objectives of the R&D Program

Customer-driven R&D is Aegis lifeline into the future, and the Aegis plant features a full-fledged R&D, with best-in-class facilities and an experienced pool of techno-professionals.
The focus of R&D here is both product-centric and customer-centric, and an all-out effort is made to meet, satisfy and exceed the customers’ existent and emergent needs and requirements.
Aegis’s R&D team, thanks to their frontline expertise, has a comprehensive understanding of the entire process & products. Thus, offer customers optimal product solutions – optimizing the total usage cost of Aegis’s products at their end.
Balancing business goals, technology objectives, and user needs attainability are three key ingredients is and finding the right mix for the company in relationship to each individual device.
The R&D projects will enable the company ample scope to enter the third-generation haemostats and sealants. It also enables the company to expand to other product portfolios and verticals in the same or other segments and benchmark as technology based company.

Comments

Post a Comment

Popular posts from this blog

Comprehensive Health Check-Up: A Commitment to Employee Well-Being

Image
Introduction In today’s fast-paced work environment, the health of employees can often take a back seat to the pressures of meeting deadlines and maintaining productivity. However, maintaining a healthy workforce is crucial for fostering a positive work environment and ensuring long-term organizational success. Regular health check-ups at the office serve as an effective means to address this challenge, ensuring that employees have access to necessary health assessments without the need to disrupt their work routines. The positive impact of these initiatives not only improves employee well-being but also reinforces the company’s commitment to a healthier workforce. This blog will delve into why these check-ups are crucial and provide insights into how they can be effectively implemented in the workplace. Aegis Lifesciences Leads the Way in Workplace Wellness It’s often said that prevention is better than cure, a principle that Aegis Lifesciences upholds in its commitment to employee he
Read more

Role of Surgi-ORC® Fibril and SURGISPON® in Posterior Fossa Tumor Resections

Image
  In posterior fossa tumor resections, Surgi-ORC® Fibril and SURGISPON® play crucial roles in facilitating a successful surgery and promoting optimal patient outcomes. Here's how they contribute to the surgical process: Hemostasis : One of the primary roles of both Surgi-ORC® Fibril and SURGISPON® is to assist in achieving hemostasis, which is the control of bleeding during surgery. Posterior fossa tumor resections can involve intricate procedures near sensitive structures such as the brainstem and cranial nerves, where bleeding must be carefully managed to maintain a clear surgical field and prevent complications. Surgi-ORC® Fibril and SURGISPON® are applied to bleeding surfaces to promote clot formation and minimize bleeding, thus enhancing visibility and surgical precision. Tissue Protection : During posterior fossa tumor resections, it's essential to protect delicate neural tissues from damage during surgical manipulation. Surgi-ORC® Fibril and SURGISPON® act as physical ba
Read more

Revolutionizing Total Knee Arthroplasty: The Role of ORC in Bleeding Control

  Effective   bleeding control   remains a formidable challenge in   modern surgery , particularly in orthopedic procedures where managing bleeding from the exposed or cut surface of cancellous bone is a critical concern.   Total knee arthroplasty   (TKA), a prevalent surgery for severe knee arthritis within orthopedics, is notably associated with significant blood loss due to extensive bone cutting and exposure of a large surface area of cancellous bone [1]. Challenges in TKA: Patients undergoing primary TKA are particularly susceptible to significant intraoperative and postoperative blood loss, leading to potential complications such as pain, decreased range of motion, and delayed recovery. With an aging population and increased life expectancy, the annual incidence of TKA procedures is expected to rise, reaching an estimated 3 million in the United States by 2030 [2]. Role of Absorbable Haemostatic Agents: To address bleeding challenges in orthopedic surgeries, particularly in TKA,
Read more